Literature DB >> 24996763

The ketamine effect on intracranial pressure in nontraumatic neurological illness.

Frederick A Zeiler1, Jeanne Teitelbaum2, Michael West3, Lawrence M Gillman4.   

Abstract

PURPOSE: The purpose of the study was to perform a systematic review of the literature on the use of ketamine in nontraumatic neurological illness and its effects on intracranial pressure (ICP).
MATERIALS AND METHODS: Articles from MEDLINE, BIOSIS, EMBASE, Global Health, HealthStar, Scopus, Cochrane Library, the International Clinical Trials Registry Platform (inception to January 2014), and gray literature were searched. Two reviewers identified manuscripts on the administration of ketamine in nontraumatic neurological illness that recorded effects on ICP. The strength of evidence was adjudicated using the Oxford and Grading of Recommendation Assessment Development and Education (GRADE) methodology.
RESULTS: Our search produced a total of 179 citations. Sixteen articles, 15 manuscripts, and 1 meeting proceeding were included in the review. Across all studies, there were 127 adult and 87 pediatric patients described. Intracranial pressure did not increase in any of the adult studies reporting premedication during ketamine administration, with 2 studies reporting a decrease in ICP. No significant non-ICP-related adverse events from ketamine were recorded in any of the studies.
CONCLUSIONS: There exists Oxford level 2b, GRADE C evidence in adults and level 4, GRADE C in pediatrics to support that ketamine does not increase ICP in nontraumatic neurological illness when patients are sedated and ventilated, and in fact may lower it in selected cases.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ICP; Intracranial pressure; Ketamine; Neurological illness

Mesh:

Substances:

Year:  2014        PMID: 24996763     DOI: 10.1016/j.jcrc.2014.05.024

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  11 in total

1.  Ten false beliefs in neurocritical care.

Authors:  Geert Meyfroidt; David Menon; Alexis F Turgeon
Journal:  Intensive Care Med       Date:  2018-03-15       Impact factor: 17.440

2.  Ketamine to treat super-refractory status epilepticus.

Authors:  Ayham Alkhachroum; Caroline A Der-Nigoghossian; Elizabeth Mathews; Nina Massad; Riva Letchinger; Kevin Doyle; Wei-Ting Chiu; Julie Kromm; Clio Rubinos; Angela Velazquez; David Roh; Sachin Agarwal; Soojin Park; E Sander Connolly; Jan Claassen
Journal:  Neurology       Date:  2020-09-01       Impact factor: 9.910

Review 3.  [Critical care management of intracerebral hemorrhage].

Authors:  V Huge
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-24       Impact factor: 0.840

Review 4.  Status epilepticus - time is brain and treatment considerations.

Authors:  Caroline Der-Nigoghossian; Clio Rubinos; Ayham Alkhachroum; Jan Claassen
Journal:  Curr Opin Crit Care       Date:  2019-12       Impact factor: 3.687

Review 5.  Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus.

Authors:  F A Zeiler
Journal:  Crit Care Res Pract       Date:  2015-01-12

Review 6.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Steven P Cohen; Anuj Bhatia; Asokumar Buvanendran; Eric S Schwenk; Ajay D Wasan; Robert W Hurley; Eugene R Viscusi; Samer Narouze; Fred N Davis; Elspeth C Ritchie; Timothy R Lubenow; William M Hooten
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288

7.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Eric S Schwenk; Eugene R Viscusi; Asokumar Buvanendran; Robert W Hurley; Ajay D Wasan; Samer Narouze; Anuj Bhatia; Fred N Davis; William M Hooten; Steven P Cohen
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288

Review 8.  Optimizing sedation in patients with acute brain injury.

Authors:  Mauro Oddo; Ilaria Alice Crippa; Sangeeta Mehta; David Menon; Jean-Francois Payen; Fabio Silvio Taccone; Giuseppe Citerio
Journal:  Crit Care       Date:  2016-05-05       Impact factor: 9.097

Review 9.  Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus.

Authors:  Michael E Reznik; Karen Berger; Jan Claassen
Journal:  J Clin Med       Date:  2016-05-19       Impact factor: 4.241

Review 10.  Ketamine in Acute Brain Injury: Current Opinion Following Cerebral Circulation and Electrical Activity.

Authors:  Christian Zanza; Fabio Piccolella; Fabrizio Racca; Tatsiana Romenskaya; Yaroslava Longhitano; Francesco Franceschi; Gabriele Savioli; Giuseppe Bertozzi; Stefania De Simone; Luigi Cipolloni; Raffaele La Russa
Journal:  Healthcare (Basel)       Date:  2022-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.